An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
Figure 1
Showing the Kaplan-Meier overall survival curve for the 112 patients receiving NCRT and the 120 patients receiving surgery resection alone. There was no significant difference in overall survival between the two groups ().